Topical Formulation Development
Tergus Pharma is a One-Stop Solution for all of Your Topical Formulation Development Needs.
Tergus has a state-of-the-art semi-solid manufacturing facility and extensive expertise in the management and...
IVRT (Franz Diffusion)
Tergus Pharma provides significant expertise in In vitro Release Rate Test (IVRT) Method Development & Validation.
Your API needs to reach its target and maintain efficacy, so skin penetration and permeation studies are a necessity.
As a CRO (Contract Research Organization), Tergus provides topical pharmaceutical R&D, testing and manufacturing services to companies of all sizes with agile and custom solutions. The industry experts in our team apply QbD (Quality by Design) principles to help you with formulation development, analysis, testing and clinical supply manufacturing. We excel in providing you with the best solution and take immense care in risk mitigation strategies.Read More
- Dawn Slann joined Tergus effective June 11, 2018 in the capacity of Senior Director, Quality Assurance.
June 13, 2018)
- Tergus Announces Key Leadership Changes
April 25, 2018)
- Access! 2019 – AAM Annual Meeting
- The 5th Annual Dermatology Innovation Forum
- 2019 AAD (The American Academy of Dermatology) Annual Meeting